Rachel Halpern

1.0k total citations
42 papers, 822 citations indexed

About

Rachel Halpern is a scholar working on Psychiatry and Mental health, Public Health, Environmental and Occupational Health and Physiology. According to data from OpenAlex, Rachel Halpern has authored 42 papers receiving a total of 822 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Psychiatry and Mental health, 7 papers in Public Health, Environmental and Occupational Health and 7 papers in Physiology. Recurrent topics in Rachel Halpern's work include Schizophrenia research and treatment (6 papers), Botulinum Toxin and Related Neurological Disorders (5 papers) and Multiple Sclerosis Research Studies (5 papers). Rachel Halpern is often cited by papers focused on Schizophrenia research and treatment (6 papers), Botulinum Toxin and Related Neurological Disorders (5 papers) and Multiple Sclerosis Research Studies (5 papers). Rachel Halpern collaborates with scholars based in United States, United Kingdom and Spain. Rachel Halpern's co-authors include Pankaj Patel, Mahesh Fuldeore, Reema Mody, Ted R. Mikuls, Carole Dembek, David Macarios, Sheikh Usman Iqbal, Lewis E. Kazis, Douglas R. Wholey and Myrlene Sanon Aigbogun and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Neurology.

In The Last Decade

Rachel Halpern

39 papers receiving 797 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rachel Halpern United States 15 170 149 147 138 100 42 822
Masayo Sato Japan 17 94 0.6× 114 0.8× 111 0.8× 235 1.7× 133 1.3× 70 958
Nishan Sengupta United States 15 139 0.8× 108 0.7× 111 0.8× 48 0.3× 312 3.1× 42 1.1k
Mona L. Martin United States 15 64 0.4× 105 0.7× 248 1.7× 41 0.3× 408 4.1× 43 1.1k
E. B. Mathiesen Norway 11 88 0.5× 44 0.3× 174 1.2× 81 0.6× 42 0.4× 14 1.1k
Claire Smith United Kingdom 11 42 0.2× 116 0.8× 162 1.1× 131 0.9× 133 1.3× 19 920
Anuradhaa Subramanian United Kingdom 21 63 0.4× 54 0.4× 205 1.4× 58 0.4× 92 0.9× 59 1.2k
Victoria Y. Strauss United Kingdom 15 50 0.3× 126 0.8× 138 0.9× 35 0.3× 35 0.3× 50 957
Paola Lucato Italy 9 77 0.5× 62 0.4× 112 0.8× 38 0.3× 41 0.4× 10 1.0k
Minako Wakasugi Japan 18 89 0.5× 37 0.2× 142 1.0× 438 3.2× 22 0.2× 63 924
Christine Perret‐Guillaume France 21 30 0.2× 103 0.7× 133 0.9× 51 0.4× 226 2.3× 42 1.3k

Countries citing papers authored by Rachel Halpern

Since Specialization
Citations

This map shows the geographic impact of Rachel Halpern's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rachel Halpern with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rachel Halpern more than expected).

Fields of papers citing papers by Rachel Halpern

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rachel Halpern. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rachel Halpern. The network helps show where Rachel Halpern may publish in the future.

Co-authorship network of co-authors of Rachel Halpern

This figure shows the co-authorship network connecting the top 25 collaborators of Rachel Halpern. A scholar is included among the top collaborators of Rachel Halpern based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rachel Halpern. Rachel Halpern is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Akazawa, Manabu, Christopher M. Blanchette, Aylin Riedel, et al.. (2021). Economic burden prior to COPD diagnosis: A matched case-control study in the United States. UNC Libraries.
4.
Buysman, Erin, Rachel Halpern, & David W. Polly. (2018). Sacroiliac joint fusion health care cost comparison prior to and following surgery: an administrative claims analysis. ClinicoEconomics and Outcomes Research. Volume 10. 643–651. 4 indexed citations
5.
Tohen, Mauricio, et al.. (2017). Patient Characteristics Associated With Use of Lurasidone Versus Other Atypical Antipsychotics in Patients With Bipolar Disorder. The Primary Care Companion For CNS Disorders. 19(3). 6 indexed citations
6.
McIntyre, Roger S., Daisy Ng‐Mak, Rachel Halpern, et al.. (2016). Major depressive disorder with subthreshold hypomanic (mixed) features: A real-world assessment of treatment patterns and economic burden. Journal of Affective Disorders. 210. 332–337. 24 indexed citations
7.
Halpern, Rachel, et al.. (2015). Adherence to Glatiramer Acetate 40 Mg Versus Oral Disease-Modifying Therapies for Multiple Sclerosis. Value in Health. 18(7). A766–A766. 3 indexed citations
8.
Halpern, Rachel, Patrick Gillard, Glenn D. Graham, Sepideh F. Varon, & Richard D. Zorowitz. (2013). Adherence Associated With Oral Medications in the Treatment of Spasticity. PM&R. 5(9). 747–756. 27 indexed citations
9.
Sweeney, Michael, et al.. (2012). PSY21 Health Care Costs Associated With Postherpetic Neuralgia and its Treatment With Gabapentin and Pregabalin. Value in Health. 15(4). A102–A102. 1 indexed citations
10.
Johnson, Phaedra, Laura Becker, Rachel Halpern, & Michael Sweeney. (2012). Real-World Treatment of Post-herpetic Neuralgia with Gabapentin or Pregabalin. Clinical Drug Investigation. 33(1). 35–44. 32 indexed citations
11.
12.
Burke, J. P., Robert J. Sanchez, Ashish V. Joshi, et al.. (2011). Health Care Costs in Patients with Painful Diabetic Peripheral Neuropathy Prescribed Pregabalin or Duloxetine. Pain Practice. 12(3). 209–218. 7 indexed citations
13.
Porter, Victoria, et al.. (2011). Outcomes associated with initiation of tiotropium or fluticasone/salmeterol in patients with chronic obstructive pulmonary disease. Patient Preference and Adherence. 5. 375–375. 20 indexed citations
14.
Halpern, Rachel, et al.. (2011). Adherence and persistence among multiple sclerosis patients after one immunomodulatory therapy failure: Retrospective claims analysis. Advances in Therapy. 28(9). 761–775. 28 indexed citations
15.
Burke, J. P., Robert J. Sanchez, Ashish V. Joshi, et al.. (2011). Health Care Costs in Patients with Fibromyalgia on Pregabalin vs. Duloxetine. Pain Practice. 12(1). 14–22. 12 indexed citations
16.
Halpern, Rachel, Smita Kothari, Mahesh Fuldeore, et al.. (2009). GERD-Related Health Care Utilization, Therapy, and Reasons for Transfer of GERD Patients Between Primary Care Providers and Gastroenterologists in a US Managed Care Setting. Digestive Diseases and Sciences. 55(2). 328–337. 19 indexed citations
17.
Halpern, Rachel, Mahesh Fuldeore, Reema Mody, Pankaj Patel, & Ted R. Mikuls. (2009). The Effect of Serum Urate on Gout Flares and Their Associated Costs. JCR Journal of Clinical Rheumatology. 15(1). 3–7. 84 indexed citations
18.
Akazawa, Manabu, Rachel Halpern, Aylin Riedel, et al.. (2008). Economic burden prior to COPD diagnosis: A matched case-control study in the United States. Respiratory Medicine. 102(12). 1744–1752. 45 indexed citations
19.
Wholey, Douglas R., et al.. (2006). Rules for Medical Markets: The Impact of Medicare Contractors on Coverage Policies. Health Services Research. 41(3p1). 721–742. 6 indexed citations
20.
Halpern, Rachel. (2005). M+C plan county exit decisions 1999-2001: implications for payment policy.. PubMed. 26(3). 105–23. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Masayo Sato Breakdown of academic impact, for papers by Nishan Sengupta Breakdown of academic impact, for papers by Mona L. Martin Breakdown of academic impact, for papers by E. B. Mathiesen Breakdown of academic impact, for papers by Claire Smith Breakdown of academic impact, for papers by Anuradhaa Subramanian Breakdown of academic impact, for papers by Victoria Y. Strauss Breakdown of academic impact, for papers by Paola Lucato Breakdown of academic impact, for papers by Minako Wakasugi Breakdown of academic impact, for papers by Christine Perret‐Guillaume
Rankless by CCL
2026